J. Rachman

First name
Last name
von Arx, L. B., Rachman, J. ., Webb, J. ., Casey, C. ., Patel, A. ., Diomatari, C. ., … Idris, I. . (2023). Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.14985
Webb, J. ., Mount, J. ., von Arx, L. B., Rachman, J. ., Spanopoulos, D. ., Wood, R. ., … Idris, I. . (2021). Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK. Diabetes Obes Metab. http://doi.org/10.1111/dom.14580